GVP Audits
Marketing Authorization (MA) Holders are required to conduct specialized GVP audits to commercial Partners whose activities may impact product safety and pharmacovigilance. The primary goal is to verify strict adherence to established agreements and prevailing regulatory requirements. These audits target a wide range of stakeholders, including Distributors, Sales Licensees, Manufacturers responsible for batch release, Pharmacovigilance Service Providers, and Local Pharmacovigilance Responsible across both EU and non-EU territories.
In accordance with Good Pharmacovigilance Practices (GVPs), audits must evaluate the adequacy and effectiveness of the pharmacovigilance and quality systems through the rigorous assessment of objective evidence.
When engaging an external service provider for GVP auditing, it is critical that the audit requirements, strategy, scope, and objectives are clearly defined. This ensures that the service provider can maintain the necessary independence and impartiality required for a valid audit.
Di Renzo Regulatory Affairs provides a dedicated GVP audit unit, featuring highly skilled specialists experienced in conducting both on-site and remote GVP audits.
